← FDA DRUG APPROVALS

FDA ANDA · ANDA211589

SUCCINYLCHOLINE CHLORIDE

Sponsor: SOMERSET THERAPS LLC

APPLICATION
ANDA211589
TYPE
ANDA
ORIGINAL APPROVAL
2020-01-15
LATEST ACTION
2023-10-02
ROUTE
INTRAMUSCULAR, INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

SUCCINYLCHOLINE CHLORIDEPrescription
SUCCINYLCHOLINE CHLORIDE 20MG/ML · INJECTABLE · INJECTION

Approval history

2023-10-02Labeling · Supplement 5 · standardAP
2021-12-03Labeling · Supplement 1 · standardAP
2020-01-15UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →